Detailed electrophysiologic evaluation of the sinus node and atrium was undertaken in 26 patients. Half had bior trifascicular conduction disease (BTD) and the others had a narrow QRS (non-BTD). BTD and non-BTD groups were comparable with respect to age, sex and incidence of coronary artery disease (CAD). One or more electrophysiologic abnormalities of the sinus node or atrium were found in nine of 13 BTD patients (more than one abnormality was present in five) and a single isolated abnormality was seen in one of 13 non-BTD patients (p < 0.01). PA interval (41 ± 3 vs 28 ± 3 msec), sinus node recovery time (1289 ± 76 vs 988 ± 44 msec), corrected sinus node recovery time (369 ± 62 vs 221 ± 35 msec), atrial effective (253 ± 14 vs 205 ± 11 msec) and functional (324 ± 15 vs 272 ± 9 msec) refractory periods were significantly longer in BTD than in non-BTD patients (p < 0.05). These differences were greatest when CAD patients were excluded and primary BTD patients (BTD without other evident cardiovascular disease) were compared with controls (narrow QRS without CAD). Sinoatrial conduction time was significantly longer in primary BTD patients (126 ± 11 msec) than it was in controls (82 8 msec).
SUMMARY Detailed electrophysiologic evaluation of the sinus node and atrium was undertaken in 26 patients. Half had bior trifascicular conduction disease (BTD) and the others had a narrow QRS (non-BTD). BTD and non-BTD groups were comparable with respect to age, sex and incidence of coronary artery disease (CAD). One or more electrophysiologic abnormalities of the sinus node or atrium were found in nine of 13 BTD patients (more than one abnormality was present in five) and a single isolated abnormality was seen in one of 13 non-BTD patients (p < 0.01). PA interval (41 ± 3 vs 28 ± 3 msec), sinus node recovery time (1289 ± 76 vs 988 ± 44 msec), corrected sinus node recovery time (369 ± 62 vs 221 ± 35 msec), atrial effective (253 ± 14 vs 205 ± 11 msec) and functional (324 ± 15 vs 272 ± 9 msec) refractory periods were significantly longer in BTD than in non-BTD patients (p < 0.05). These differences were greatest when CAD patients were excluded and primary BTD patients (BTD without other evident cardiovascular disease) were compared with controls (narrow QRS without CAD). Sinoatrial conduction time was significantly longer in primary BTD patients (126 ± 11 msec) than it was in controls (82 8 msec).
We conclude that electrophysiologic abnormalities of the sinus node and atrium are extremely common in patients with BTD, particularly primary BTD, and may cause symptomatic dysrhythmias. SEVERAL STUDIES HAVE SHOWN increased morbidity and mortality in patients with bi-and trifascicular conduction disease (BTD).'-" The current uncertainty and controversy about this type of conduction disease center on the role of atrioventricular (AV) block as the cause of symptoms and death. The value of a prolonged HV interval (i.e., trifascicular conduction disease) as a harbinger of advanced AV block and the need for "prophylactic" pacemakers in the latter patients have been particularly controversial.3' I Less attention has been given to sinus node and atrial dysfunction as a cause of morbidity and mortality in patients with BTD. Patients with sinoatrial conduction disorders (sick sinus syndrome) have a high incidence of distal conduction disease,8' but the converse relationship has not, to our knowledge, been shown. Therefore, we undertook electrophysiologic assessment of sinus node and atrial function in patients with bundle branch block.
Materials and Methods
The subjects were selected from patients undergoing diagnostic or investigational electrophysiologic study, coronary and left ventricular angiography, or hemodynamic cardiac catheterization and who met the study criteria. Informed consent was obtained.
Details of the study population are provided in table 1. The patients were divided into four subgroups.
Group IA. Eight patients with a narrow QRS (<0.09 second). Seven patients had atypical chest pain with normal coronary and left ventricular angiograms, and the other patient in this group had idiopathic orthostatic hypotension. These eight patients were considered controls.
Group lB. Five patients with a narrow QRS and coronary artery disease (CAD) proven by one or more of the following: documented myocardial infarction (MI), angina, or coronary angiography.
Group 2A. Eight patients with bifascicular conduction disease by surface ECG, as previously defined.' These patients had no other evident cardiovascular disease by history and examination, or by other tests that were performed when clinically indicated,5 6 and were considered to have primary conduction disease. Some patients considered to have primary conduction disease could have had occult CAD.
Group 2B. Five patients with bifascicular conduction disease by surface ECG also had CAD proven by one or more of the following: documented MI, angina, or coronary angiography.
Any medication that might have an effect on the conduction system was discontinued at least five halflives before the study. The eight patients in group 2A were consecutively selected from patients undergoing an investigational electrophysiologic study. Continuous Holter-type monitoring was not routinely performed on all patients. The patients with transient neurological symptoms were monitored. Three of 13 patients each in groups 1 and 2 had at least one 24hour period of Holter-type monitoring. The only additional finding on these recordings was one patient in group 2A who had some brief episodes of sinus arrest. All patients were studied in the postabsorptive state and some were mildly sedated with oral ben- Three-vessel CAD Abbreviatioins: AOf)M = adult onset diabetes mellit us; APCs = atrial extrasystoles; AS = aortic stenosis; Ca = carcinoma; CABG = coronary artery bypass graft; CAD = coronary artery disease; IDN = isosorbide dinitrate; IMI = inferior myocardial infarction; LAI) = left-axis deviation; LAHB -left anterior hemiblock; LBBB = left bundle branch block; LPHB = left posterior hemiblock; LVH = left ventricular hypertrophy; Nl) = not done; NSSTT = nonspecific ST-T changes; NTG = nitroglycerin; RBBB = right bundle branch block; s/p = superior-posterior; VPCs = ventricular extrasystoles; WNL = within normal limits; 1°AV = first-degree atrioventricular block.
zodiazapines. Techniques of electrode catheter placement and electrophysiologic measurements have been previously described.6' 10, 11 Control intracardiac intervals (PA, AH and HV intervals) were recorded during the subject's spontaneous sinus rhythm. Right atrial stimuli at approximately twice diastolic threshold were introduced after every eighth beat during the subject's spontaneous sinus rhythm. Atrial refractory periods were also determined at a paced atrial rate of 110 beats/min (cycle length 546 msec). Stimuli were introduced starting at approximately three-fourths of electrical diastole, then at decreasing coupling intervals until atrial capture was lost. Duplicate sinus node recovery times (SNRTs) were determined after 1 minute of atrial overdrive suppression at 110, 120 and 130 beats/min.
Definition of Terms
PA interval. The time from the earliest onset of P in any surface ECG lead (or high right atrial electrogram if P not visible) to the first high-frequency deflection of *Longest SNRT or CSNIIT regardless of the rate of overdrive suppression.
Abbreviations: AP = atrial pacing; CL = cycle length; CP = chaotic pattern; CSNRT = corrected sinus node recovery time; ERP = effective refractory period; FRP functional refractory period; ND = not done; SACT = sinoatrial conduction time; SNRT = sinus node recovery time; SR = sinus rhythm. the low right atrial electrogram (normal < 45 msec).'0 AH interval. The time from the first high-frequency deflection of the low right atrial electrogram to the first high-frequency deflection of the His bundle electrogram (normal < 130 msec).'0 HV interval. The time from the first high-frequency deflection of the His bundle electrogram to the earliest onset of the QRS in the surface ECG (any lead) (normal < 55 msec).'0 A trial effective refractory period (atrial ERP). The longest A,S (or S,S, during paced rhythm) at which S (S,) fails to capture the atrium; S, S, and S, represent the stimulus artifact. In this and subsequent definitions, A,, A, or A, represent the first highfrequency deflection in the high right atrial electrogram. At a paced rate of 110 beats/min, the normal atrial ERP is < 335 msec." Atrial functional refractory period (atrial FRP). The shortest A,A, that results from any A,S (or S,S2 during paced rhythms). At a paced rate of 110 beats/min, the normal atrial FRP is < 365 msec."
Sinus node recovery time. The time from the last stimulus artifact to the earliest onset of P in any surface ECG lead (or high right atrial electrogram if P not visible) (normal < 1680 msec).10
Corrected sinus node recovery time (CSNRT). The SNRT minus the cycle length. The cycle length was determined from an average of a minimum of six consecutive cycles recorded at the beginning of the study (normal < 500 msec)." Zone of reset." The zone in which return cycles are relatively constant and greater than the spontaneous cycle length.
Sinoatrial conduction time (SA CT). A minimum of 10 reset cycles was averaged and an unequivocal reset zone was identified in all patients in whom SACT was calculated (normal < 120 msec). [13] [14] [15] Data are presented as the mean + SEM. Differences were analyzed by partitioning of chi squares,'6 unpaired t test,'7 or analysis of variance17 and Duncan's multiple range test,'8 and considered significant when p < 0.05. 
Results
The CAD patients were all males; there were two females each in groups 1 and 2. There was no significant difference in age between groups 1 and 2 (51 ± 3 vs 61 ± 5 years; p > 0.05 by unpaired t test; p = 0.29 by analysis of variance). Though the 10-year difference in age between groups 1 and 2 is not statistically significant, the sample size is such that we cannot determine if this difference is biologically significant.
None of the patients in group 1 had prolonged AH or HV intervals. One patient in group 2 had a prolonged AH interval, but there was no significant difference between the mean AH interval of groups 1 and 2 (84 ± 8 vs 94 ± 6 msec; NS). AV node function was not evaluated in all group 1 patients because of the study design. However, three group 2 patients had abnormal AV node function (prolonged AH interval in two, increased AV nodal ERP and FRP in one, and AV node Wenckebach rhythm at a paced atrial rate of less than 130 beats/min in two)."2 One patient in group 2 had a prolonged HV interval. The mean HV interval of group 2 patients was significantly longer than that of group 1 patients (48 ± 2 vs 36 ± 3 msec; p < 0.001 by unpaired t test and p = 0.025 by analysis of variance). There was no difference in AH or HV intervals in the subgroups of groups 1 and 2.
All patients in groups IA, lB and 2B had normal sinus rhythm (rate 60-100 beats/min), but three patients in group 2A had sinus bradycardia (52, 54 and 58 beats/min) at the time of study. The cycle length of group 2 patients was significantly longer than that of group 1 patients (904 ± 38 vs 779 ± 26 msec; p < 0.01 by unpaired t test and p = 0.06 by analysis of variance), although there was no significant difference within groups 1 or 2 by multiple range test.
The abnormalities of the sinus node and atrium found at electrophysiologic study in these patients are noted in tables 2 and 3. There was a significantly higher incidence of these abnormalities in group 2 patients when compared with group I patients, but no significant differences within groups 1 and 2 (partitioning of chi squares group 2A and two of five patients in group 2B had one or more electrophysiologic abnormalities of the sinus node or atrium; thus, nine of 13 patients in group 2 had one or more of these abnormalities. Five of these nine patients in group 2 had more than one abnormality. One patient in group IA had a slightly prolonged SACT (123 msec); thus, only one of 13 patients had electrophysiologic abnormalities of the sinus node or atrium. mentioned measures of sinus node and atrial function ( fig. 3, table 4 ). SACTs only tended to be longer when all BTD patients (group 2) were compared with all non-BTD patients (group 1), but this difference was not significant. However, primary BTD (BTD without other evident heart disease) patients (group 2A) had significantly longer SACTs than either controls (group 1 A) or patients with BTD and CAD (group 2B) and patients with CAD and a narrow QRS (group I B), although the last difference was not significant. The incidence of atrial echo zones provoked by right atrial extrastimuli, whether or not the echo resulted in supraventricular tachyarrhythmia, was similar in all groups (table 5). Four of 13 patients in group 1 and four of 13 patients in group 2 had isolated atrial echo zones during either sinus rhythm or atrial pacing, and these were equally divided between patients with or without CAD. Two of 13 patients in group 1 and two of 13 patients in group 2 had atrial echo zones producing supraventricular tachyarrhythmia.
Discussion
Detailed intracardiac electrophysiologic evaluation showed one or more abnormalities of the sinus node or atrium in nine of 13 patients (more than one abnormality in five of the nine) with BTD (group 2). The incidence was particularly striking in patients in group 2A (primary BTD); seven of eight of these patients had one or more electrophysiologic abnormalities of the sinus node or atrium. Only one non-BTD patient (group 1) had a single isolated abnormality (mildly prolonged SACT). The difference in the incidence of abnormalities between BTD patients (group 2) and non-BTD patients (group 1) was highly significant. The PA interval, SNRT, CSNRT and atrial ERPs and FRPs were longer in BTD than in non-BTD patients. When patients were subdivided into those with and those without CAD, the latter differences in sinoatrial function were greatest when primary BTD patients (group 2A) were compared with control patients (group IA). The SACT was longer only in primary BTD patients. The incidence of sinus node or atrial echo zones or supraventricular tachyarrhythmia provoked by atrial extrastimuli was not different between any group. One of the electrophysiologic measurements selected for the present study was SACT. The upper limit of normal for this parameter is controversial. One earlier published normal value was derived from a group of subjects composed largely of patients with bundle branch block." More recent studies'3-' have reported the normal value to be lower, 120 msec or less. In our study the mean SACT (+2 SD) of the control group was 122 msec, a value in keeping with these latter reports. The finding in the present study that primary BTD patients have a significantly higher SACT may partly explain the discrepancy in the earlier reports of the upper limits of normal for this parameter." SACT, however, is an indirect measurement of the conduction time between the sinoatrial node and the atrium, and depends on the duration and refractoriness of the sinoatrial node pacemaker and conduction through perinodal tissue, as well as on atrial conduction.'3 l Groups I and 2 were comparable with respect to age, sex, and incidence of CAD. The initial distinguishing feature between the two groups was the presence of bundle branch block in all patients in group 2. Twelve of the latter patients had bifascicular disease (left bundle branch block or right bundle branch block and axis deviation, and a normal HV interval) and one patient had trifascicular conduction disease (bifascicular disease and a prolonged HV interval). AV node function was evaluated only in group 2 patients, and abnormalities were relatively infrequent, occurring in three of 13.
The high incidence of distal conduction disease in patients with sinoatrial conduction abnormalities (sick sinus syndrome) is well-known.8' 9 The reverse relationship, that is, a high incidence of sinus node and atrial dysfunction in patients with BTD, has not, to our knowledge, been previously reported. The present work clearly shows a high incidence of such abnormalities in patients with primary BTD. The presence of CAD is a confounding variable, and when patients with CAD are included, the relationship between BTD and sinus node or atrial dysfunction is somewhat obscured.
The reason primary BTD patients (group 2A) differ from those with BTD and CAD patients (group 2B) probably lies in differences in the etiology of conduction disease in groups 2A and 2B. Primary conduction disease is generally considered to be a sclerodegenerative process20' 21 that involves the conducting system diffusely; therefore, it is not surprising that patients with disease in the bundle branches would also be likely to have disease in the sinus node and atrium, as suggested by our data. Conduction disease due to CAD, however, is dependent on the distribution of the affected coronary arteries and the extent of myocardial involvement. For example, it has been clearly shown in CAD patients that SACT is correlated with the presence or absence of disease of the sinus node artery.'4
Clinical Implications
It is well known that patients with BTD have increased morbidity and mortality. -7 The current focus of attention in the literature has attempted to relate the symptoms in these patients to advanced AV block. We suggest that dysrhythmias due to sinus node and atrial dysfunction should be considered as a cause of symptoms and death in these patients. The symptoms in such patients may be due to a supraventricular rhythm disturbance or to systemic emboli, because patients with the tachy-brady variant of sinoatrial disease are known to be at increased risk of morbidity and mortality from embolic events.2" 23 We have shown the incidence of sinus node and atrial abnormalities in patients with bundle branch block, but the clinical significance of our results needs further evaluation.
